ESR1 and breast carcinoma: For example, estrogens and endocrine disrupting chemicals (EDCs) such as benzophenon-1 and nonylphenol spur metastasis through overexpression of cathepsin D in MCF-7 breast cancer cells via the ER-dependent signaling pathway [17,18].